To Top

Search By Topic

Drug Delivery

43 Articles available
Drug Delivery

The Chemistry Inside Innovation

Donald Loveday, Ph.D., Customer Applications Director, Pharma and Medical, Celanese

PTV-M06-17-BIO-001
Drug Delivery

The Future Of Uniquely Delivered Drugs and ADCs

MCP-M07-17-NI-020
Drug Delivery

Harvard University Researchers Develop Ultrasound/Nanoparticle Method for Targeted Delivery of Chemotherapeutics

PAO-M06-17-NI-015
Drug Delivery

Unither Pharmaceuticals on the Road to BIO: Innovation in Delivery

David Kudla, General Manager for North America, Unither Pharmaceuticals. View more about Unither Pharmaceuticals on the Road to BIO.

PTV-M06-17-CL-002
Excipients

Celanese on the Road to BIO: Excipients In Biologics

Dr. Donald Loveday – Customer Applications Director, Pharma and Medical, Celanese. View more about Celanese on the Road to BIO.

PTV-M06-17-CL-010
Drug Delivery

Vetter and Microdermics Will Develop Microneedle Delivery Systems

PAO-M06-17-NI-008
Regulatory

Moving Quality to the Forefront Brings Measurable Results

PAP-Q2-17-CL-008
Drug Delivery

The Search for Alternative Delivery Methods Continues

PAP-Q2-17-FA-003
Drug Delivery

The People’s Choice: Premeasured Single Dosage Forms

PAP-Q2-17-CL-014
Drug Delivery

Trends in the Topical Delivery of Dermatology Medications

MCM-M05-NI-001
Biologics

Dan Peizer Reveals Catalant’s Newest Acquisition

Dan Peizer, Global Director of Corporate Marketing, Catalent

PTV-M11-16-AP-027
Formulation

Focusing on Patient Compliance

Brian Wilson, Technical Development Manager, SPI Pharma

PTV-M01-17-NS-011
Innovation

The Latest Developments at Triskelion

Tineka Meijers, VP, Business Development, Triskelion, TNO Predictive Health Technologies

PTV-M11-16-AP-004
Formulation

Innovative Drug Delivery Technology

Kevin Haehl, General Manager, North America, Unither Pharmaceuticals

PTV-M11-16-AP-006
Drug Delivery

Breakthrough Drug Delivery Technology

Tobias Bachle, Sales Director, Pantec Biosolutions

PTV-M11-16-AP-022
Discovery

New Ventures in the Microbiome

PAP-Q1-17-TT-001
CDMO

Pharma’s Reputation Gap: Consumer Business Innovation

PAP-Q1-17-CL-009
API

Achieving Security of Supply with Effective Particle Engineering

PAP-Q1-17-CL-002
Equipment

Stay Tuned: Pharma’s Almanac TV Goes Live

PAP-Q1-17-PT-001
CDMO

Human Factors Engineering and the Variability of the Human Condition

APR-M02-17-NI-001
Drug Delivery

Advances in Delivering Protein and Peptide Therapeutics

PTO-M11-16-NI-001
Excipients

What’s New at AAPS: Materials

PAP-M11-16-NI-001
API

A Look at Recent Pharma Industry Innovations

PAP-Q04-16-NO-001
Formulation

Better Design, Better Outcomes, Better Economics

PAP-Q04-16-IL-001
API

Dry-Powder Inhalation Formulation: Balancing Performance and Manufacturability

PAP-Q04-16-CL-006
API

Capsugel’s Transformation: Q&A with Guido Driesen

PAP-Q04-16-QA-001
Packaging

Advancing Patient-Centric Parenteral Drug Strategies

PAP-Q04-16-CL-001
CDMO

Patient-Centric Drug Development: Designing Medicines to Succeed

PAP-Q03-16-CL-004
API

Embracing Formulation Expertise to Extend Exclusivity & Improve the Patient Experience

PAP-Q03-16-CL-005
Clinical Trials

Dose and Form Matter: Future of Care Demands Optimal Drug Delivery

PAP-Q02-16-CL-003
Excipients

Optimising Excipients to Improve Bioavailability

MCP-M03-16-NI-001
CDMO

The Importance of Convenient Dosing Formulations for Elderly Patients

PAP-Q1-16-CL-008
API

Patient Safety and Parenteral Delivery Systems

PAP-Q1-16-CL-010
API

Strong CMO/CDMO Market Outlook for 2016, but Beware Moderating Factors

PAP-Q1-16-FA-001
API

Bolstering Capabilities for Parenteral Drug Development and Manufacturing

PAP-Q4-15-CL-005
Patient Adherence

Why Innovative Drug Delivery Packaging Solutions Are Needed for Today’s Patients

PAP-APR-S01-CL-003
Biologics

Pre-filled Syringe Technology Benefits Patients, Healthcare Providers and Drug Makers

CIO-M06-14-NI-001
CDMO

New Technologies In Fill-Finish May Bring Brand Loyalty Along with Improved Patient Safety

LSL-M04-14-NI-001
Biologics

CROs and CMOs Continuing Drug Delivery Innovation

CIO-M08-13-NI-001
Formulation

Outsourcing and the Oral Solid Dose: Will Challenges Lead to New Patterns of Outsourcing?

CIO-M06-13-NI-001
Outsourcing

What CROs and CMOs Can Learn from Q3 Outsourcing Data and 2011 Trends

PQO-M11-11-NI-001
CMO

Sterile Manufacturing Opportunities

PPO-M10-11-NI-001
//Fix for text overflow in cards